Clinical trials: Cancer Patients and Physical Activity
Chronic Lymphocytic Leukemia (CLL)
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Chronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of blood cells). The purpose of this study is to assess retreatment with venetoclax-obinutuzumab (VenG) in participants previously treated with fixed duration…
- Trial name
- ReVenG (NCT04895436)
- Testing
- Venetoclax, Obinutuzumab
- Where
- 58 sites in United States, Australia and 9 more
- Volunteers
- 75 people
- Sponsor
- AbbVie
Metastatic Solid Tumors, Locally Advanced Solid Tumors
This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors.
The purpose of this study is to establish the maximum tolerated dose (MTD) of OBI-888 as monotherapy. And to characterize the safety and preliminary clinical activity profile of the MTD dose of OBI-888 administered as monotherapy…
- Trial name
- NCT03573544
- Testing
- OBI-888, Globo H IHC Assay
- Where
- 9 sites in United States, Taiwan
- Volunteers
- 54 people
- Sponsor
- OBI Pharma, Inc
Pancreas Adenocarcinoma (MSI-H), Deconditioning
Exercise to Improve Outcomes in Pancreatic Cancer
Pancreatic cancer surgery (Whipple's procedure) is a major operation that can lead to reduced physical fitness, delayed recovery, and difficulty starting chemotherapy after surgery.
- Trial name
- ExO-PanC (NCT07710495)
- Testing
- ExO-PanC Personalised Exercise Programme
- Where
- United Kingdom
- Volunteers
- 60 people
- Sponsor
- University of Surrey
Breast Cancer, Fatigue
Mindfulness and Self-compassion Focussed Walking
This research study is evaluating the effects of two training programs (1. Walking, 2. Mindfulness and Self-compassion focussed Walking) on tumor-specific symptoms of fatigue in women with breast cancer undergoing chemo- and/or…
- Trial name
- MSCW (NCT04193644)
- Testing
- Mindfulness and Self-Compassion focussed exercises during walking training, Walking training
- Where
- 2 sites in Germany
- Volunteers
- 135 people
- Sponsor
- Charite University, Berlin, Germany
Advance Solid Tumors, Lymphoma, Non-Hodgkin
Study of JMBI-001 in Patients With MYC-Positive Advanced Cancers
Evaluate the safety and tolerability of JMBI-001 in adults with MYC-positive advanced cancers.
- Trial name
- PANGU-1 (NCT07864701)
- Testing
- JMBI-001 Tablets
- Where
- China
- Volunteers
- 150 people
- Sponsor
- Chengdu Anticancer Bioscience, Ltd.
Melanoma
Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel
This is an open, monocentric, pilot study to determine the metabolic activity (glucose-uptake) in vivo during monotherapy with pazopanib in comparison to combination therapy with pazopanib plus paclitaxel and to investigate the…
- Trial name
- NCT01666418
- Testing
- Pazopanib/Paclitaxel
- Where
- Switzerland
- Volunteers
- 19 people
- Sponsor
- University of Zurich
Lymphoma, Non-Hodgkin
A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18
The purpose is to identify a dose of SB-485232 which is safe, tolerable and effective when used in combination with Rituximab in patients with non-Hodgkin's lymphoma (NHL).
- Trial name
- NCT00500058
- Testing
- SB-485232, Rituximab
- Where
- 2 sites in United States
- Volunteers
- 24 people
- Sponsor
- GlaxoSmithKline
Advanced Solid Tumor
A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors
This clinical trial is a multicenter, open, single-arm, non-randomized, dose-escalation and dose-expansion, phase I clinical study in patients with advanced recurrent or metastatic solid tumors.The goal of this study is to…
- Trial name
- NCT06307925
- Testing
- HC010
- Where
- China
- Volunteers
- 122 people
- Sponsor
- HC Biopharma Inc.
Uveal Melanoma, Choroid Neoplasm
Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma
The purpose of this study is to evaluate the safety, tolerability, biological activity, pharmacokinetics and pharmacodynamic activity of single and repeated escalating intravitreal doses of ICON-1 in patients with primary uveal…
- Trial name
- NCT02771340
- Testing
- ICON-1
- Where
- 8 sites in United States
- Volunteers
- 10 people
- Sponsor
- Iconic Therapeutics, Inc.
Solid Tumor, NSCLC
JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors
To evaluate the safety and tolerability of JAB-3312 administered in investigational regimens in adult participants with advanced solid tumors.
- Trial name
- NCT04720976
- Testing
- JAB-3312, Binimetinib, Pembrolizumab
- Where
- 15 sites in United States
- Volunteers
- 58 people
- Sponsor
- Allist Pharmaceuticals, Inc.
Colorectal Cancer
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
High blood pressure (hypertension) is a known side effect of the treatment with fruquintinib. Current research does not provide a clear answer whether minority groups such as Black/African American and/or Hispanic/Latino with…
- Trial name
- NCT06562543
- Testing
- Fruquintinib
- Where
- 45 sites in United States, Puerto Rico
- Volunteers
- 78 people
- Sponsor
- Takeda
Metastatic or Locally-advanced Digestive Cancer
The Enzymatic Activity of Lymphocyte Dihydropyrimidine Dehydrogenase DPD in the Blood as a Predictive and Prognostic Factor in Patients With Digestive Cancer in the First or Second Metastatic Line
An observational study of a prospective, analytical, monocentric cohort which does not modify the patient care because the phenotyping of the dihydropyrimidine déshydrogénase DPD (lymphocyte activity) is already carried out in…
- Trial name
- DPD DIG (NCT03205735)
- Testing
- lymphocyte DPD dosage
- Where
- France
- Volunteers
- 200 people
- Sponsor
- Centre Antoine Lacassagne
Precancerous Condition, Prostate Cancer
Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer
RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of fish oil and/or green tea may prevent prostate cancer.
- Trial name
- NCT00253643
- Testing
- green tea catechin extract, fish oil
- Where
- 3 sites in United States
- Volunteers
- 89 people, healthy volunteers welcome
- Sponsor
- OHSU Knight Cancer Institute
Malignant Pleural Mesothelioma
ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)
The purpose of this study is to determine whether trabectedin is effective in the treatment of malignant pleural mesothelioma (MPM).
- Trial name
- ATREUS (NCT02194231)
- Testing
- Trabectedin
- Where
- 8 sites in Italy
- Volunteers
- 145 people
- Sponsor
- Mario Negri Institute for Pharmacological Research
Head and Neck Cancer
Pre-treatment Exercises Versus Post-treatment Exercises for Dysphagia
The purpose of this project is to determine if pre-treatment swallowing exercises can improve post-treatment swallowing function in patients undergoing radiation with or without chemotherapy for advanced squamous cell carcinoma…
- Trial name
- NCT00584129
- Testing
- Pre-treatment swallowing exercises, Post-treatment swallowing exercises.
- Where
- United States
- Volunteers
- 52 people
- Sponsor
- University of Alabama at Birmingham
Metastatic Breast Cancer, 70 Years Old Patients and Over
Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.
GERICO 09/0907 is a Phase II multicentric trial evaluating the toxicity and activity of the combination of lapatinib and capecitabine in locally advanced or metastatic breast cancer over expressing HER2 for patients aged ≥ 70 who…
- Conditions
- Metastatic Breast Cancer, 70 Years Old Patients and Over, After One Line of Chemotherapy With Trastuzumab
- Trial name
- GERICO09 (NCT01262469)
- Testing
- lapatinib + capecitabine
- Where
- 20 sites in France
- Volunteers
- 4 people
- Sponsor
- UNICANCER
Multiple Myeloma, Adapted Physical Activity
Benefits of Adapted Physical Activity for Chronic Osteoarticular Pain in Patients With Multiple Myeloma
Pain is one of the most frequent symptoms leading patients to consult a doctor, particularly in rheumatology and cancerology. When it becomes chronic, pain is the cause of a major emotional and physical invasion, with harmful…
- Conditions
- Multiple Myeloma, Adapted Physical Activity, Chronic Pain
- Trial name
- ALGOMYELOMOV (NCT05548686)
- Testing
- adapted physical activity
- Volunteers
- 15 people
- Sponsor
- University Hospital, Caen
Cancer, Physical Activity
Fitness Trackers During and After Oncological Treatments
The overall goal of the present trial is to evaluate the patients' compliance for wearing a commercially available fitness tracker during and after oncological treatments.
- Conditions
- Cancer, Physical Activity, Fatigue
- Trial name
- NCT03610854
- Testing
- Fitness Tracker
- Where
- Germany
- Volunteers
- 50 people
- Sponsor
- University Hospital Tuebingen
Richter's Transformation
Selinexor in Initial or Refractory and/or Relapsed Richter's Transformation
This is a multi-center, phase 2, single arm, open-label study of oral selinexor monotherapy in patients with Richter's Transformation, arising in the setting of prior chronic lymphocytic leukemia (CLL), after at least one…
- Trial name
- SIRRT (NCT02138786)
- Testing
- selinexor
- Where
- 17 sites in United States, Germany and 3 more
- Volunteers
- 27 people
- Sponsor
- Karyopharm Therapeutics Inc
Tumor Lysis Syndrome
Elitek (Rasburicase) Immuno-Monitoring Study
Primary Objective: To determine the incidence, titer and type of anti-rasburicase antibodies in the context of hypersensitivity reaction(s) or the loss of uricolytic activity occurring in patients with relapsed leukemia/lymphoma…
- Trial name
- NCT01097369
- Where
- 4 sites in United States
- Volunteers
- 1 people
- Sponsor
- Sanofi
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.